01.05.2024 - Significant POLB 001 Patent Granted in United StatesImmunomodulator II patent grant further strengthens robust intellectual property portfolio for partnering LONDON, UK / ACCESSWIRE / May 1, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF, Poolbeg or . Seite 1
21.11.2023 - Further enhancement of the patent portfolioLONDON, UK / ACCESSWIRE / November 21, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), Poolbeg or the Company ), a biopharmaceutical company focussed on the development and commercialisation of innovative . Seite 1